Lilly to launch three products in 2003
October 21, 2003Eli Lilly is to embark on an ambitious product launch schedule over the next two years to overcome the patent …
Bayer open to takeover bids
October 21, 2003The Chief Executive of Bayer has conceded the company cannot continue alone, and has now declared the company open to …
Alzheimer drugs rationing continues despite NICE guidelines
October 21, 2003Alzheimer's patients in a quarter of all health authorities are still not receiving the latest medicines despite NICE guidance being …
Europe to mimic US research ‘clusters’
October 21, 2003New networks of excellence in pharmaceutical research must be established if Europe is to catch up with world leading US …
Crestor approval lifts AstraZeneca
October 21, 2003AstraZeneca has been boosted by the first regulatory approval in the Netherlands of Crestor, its 'superstatin' cholesterol treatment.The drug is …
OTC advertising regulations to be relaxed
October 21, 2003A ban on advertising some OTC medicines could be lifted as part of the Government drive to create a patient-centred …
Patients to report drug side-effects to NHS
October 21, 2003Patients will be able to report adverse reactions to medicines direct to the NHS from next year, the Government has …
AZ launches Zomig nasal spray
October 21, 2003AstraZeneca has launched a new fast acting nasal spray version of its migraine treatment Zomig.The product is intended to bypass …
The Consumer Age
October 21, 2003Medical Communications empowered, patients
The growing influence of patient advocacy groups (PAGs) such as the Patients Association is evidence of patient power flexing its …
Shire’s chief steps down
October 21, 2003Shire's chief executive Rolf Stahel is to stand down after reports of a widening rift with US non-executive directors and …
Elan running $1bn loss
October 21, 2003Elan reported a net loss of $1 billion for the third quarter, following charges of $943 million.A significant portion of …
Bayer healthcare chief quits
October 21, 2003The head of Bayer's healthcare unit, Frank Morich, has resigned as troubles at the German company continue.Bayer is cutting back …
Medicines Partnership would involve industry
October 21, 2003The Medicines Partnership, a Department of Health scheme that promotes patient compliance, would lend its support to pharmaceutical industry projects. The …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
